These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 3998764

  • 1. Induction by interferon-alpha of tumoricidal activity of adherent mononuclear cells from human blood: monocytes as responder and effector cells.
    Sone S, Utsugi T, Shirahama T, Ishii K, Mutsuura S, Ogawara M.
    J Biol Response Mod; 1985 Apr; 4(2):134-40. PubMed ID: 3998764
    [Abstract] [Full Text] [Related]

  • 2. [Induction of human monocyte-mediated tumor cell killing by alpha or beta interferon].
    Utsugi T, Mutsuura S, Ogawara M, Shirahama T, Ishii K, Tsubura E, Sone S.
    Gan To Kagaku Ryoho; 1985 May; 12(5):1105-10. PubMed ID: 3994398
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
    Utsugi T, Sone S.
    J Immunol; 1986 Feb 01; 136(3):1117-22. PubMed ID: 3079797
    [Abstract] [Full Text] [Related]

  • 4. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR, Kamber M, Peck R.
    Lymphokine Res; 1987 Feb 01; 6(3):215-27. PubMed ID: 3114569
    [Abstract] [Full Text] [Related]

  • 5. [Effect of interferon-alpha (MOR-22) on human NK cell activity].
    Yanagihara Y, Tochizawa S, Ishii K, Hirai Y.
    Gan To Kagaku Ryoho; 1986 Feb 01; 13(2):342-8. PubMed ID: 3947110
    [Abstract] [Full Text] [Related]

  • 6. IFN-alpha and IFN-gamma can affect both monocytes and tumor cells to modulate monocyte-mediated cytotoxicity.
    Webb DS, Gerrard TL.
    J Immunol; 1990 May 01; 144(9):3643-8. PubMed ID: 2158515
    [Abstract] [Full Text] [Related]

  • 7. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F, Peri G, Villa A, Mantovani A.
    J Immunol; 1984 Feb 01; 132(2):936-44. PubMed ID: 6690624
    [Abstract] [Full Text] [Related]

  • 8. [Studies on the antitumor activity of human recombinant interferon alpha-2b in vitro].
    Haraguchi S, Koide Y, Matsuo T, Yoshida TO.
    Gan To Kagaku Ryoho; 1986 Oct 01; 13(11):3236-43. PubMed ID: 2946265
    [Abstract] [Full Text] [Related]

  • 9. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide.
    Munakata T, Semba U, Shibuya Y, Kuwano K, Akagi M, Arai S.
    J Immunol; 1985 Apr 01; 134(4):2449-55. PubMed ID: 3919096
    [Abstract] [Full Text] [Related]

  • 10. [Induction of tumoricidal properties in human monocytes by synergism between interferon-gamma and liposome-entrapped muramyl tripeptide].
    Utsugi T, Sone S, Tandon P, Ogawara M, Shimizu E, Nii A, Nakanishi M, Shono M, Ogura T.
    Gan To Kagaku Ryoho; 1986 Oct 01; 13(11):3161-8. PubMed ID: 3096216
    [Abstract] [Full Text] [Related]

  • 11. Monocyte and NK cell cytotoxic activity in human adherent cell preparations: discriminating effects of interferon and lactoferrin.
    Horwitz DA, Bakke AC, Abo W, Nishiya K.
    J Immunol; 1984 May 01; 132(5):2370-4. PubMed ID: 6201542
    [Abstract] [Full Text] [Related]

  • 12. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
    Platsoucas CD, Fox FE, Oleszak E, Fong K, Nanno M, Ioannides CG, Trotta PP.
    Anticancer Res; 1989 May 01; 9(4):849-58. PubMed ID: 2817813
    [Abstract] [Full Text] [Related]

  • 13. Human peripheral blood monocytes are susceptible to interferon-activated natural killer cells.
    Einhorn S, Anderbring E.
    J Clin Lab Immunol; 1985 Apr 01; 16(4):197-9. PubMed ID: 4020850
    [Abstract] [Full Text] [Related]

  • 14. Interferon as a macrophage activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals.
    Dean RT, Virelizier JL.
    Clin Exp Immunol; 1983 Mar 01; 51(3):501-10. PubMed ID: 6342884
    [Abstract] [Full Text] [Related]

  • 15. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
    Fitzgerald PA, Mendelsohn M, Lopez C.
    J Immunol; 1985 Apr 01; 134(4):2666-72. PubMed ID: 2982949
    [Abstract] [Full Text] [Related]

  • 16. Properties of human natural interferon-producing cells stimulated by tumor cell lines.
    Rönnblom L, Ramstedt U, Alm GV.
    Eur J Immunol; 1983 Jun 01; 13(6):471-6. PubMed ID: 6574913
    [Abstract] [Full Text] [Related]

  • 17. Membrane-associated interleukin 1 alpha as a mediator of tumor cell killing by human blood monocytes fixed with paraformaldehyde.
    Okubo A, Sone S, Tanaka M, Ogura T.
    Cancer Res; 1989 Jan 15; 49(2):265-70. PubMed ID: 2463072
    [Abstract] [Full Text] [Related]

  • 18. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
    Bloom ET, Babbitt JT, Kawakami K.
    J Immunol; 1986 Jul 01; 137(1):172-8. PubMed ID: 3711665
    [Abstract] [Full Text] [Related]

  • 19. Eradication of cultured human melanoma cells by immune interferon and leukocytes.
    Tyring SK, Klimpel G, Brysk M, Gupta V, Stanton GJ, Fleischmann WR, Baron S.
    J Natl Cancer Inst; 1984 Nov 01; 73(5):1067-73. PubMed ID: 6436563
    [Abstract] [Full Text] [Related]

  • 20. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
    Karavodin LM, Golub SH.
    Nat Immun Cell Growth Regul; 1984 Nov 01; 3(4):193-202. PubMed ID: 6241293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.